Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.

Chronic Pain Clinical Trial

— SCS  

Official title:

Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01137617
• Other study ID #: 2010P 000425
• Status: Completed
• Start date: June 2010
• Est. completion date: December 20, 2016

Study information

• Verified date: July 2020
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to better understand how the Spinal Cord Stimulator works in relieving chronic pain.

The investigators are asking subject to take part in this study because who are chronic pain patients who already have a Spinal Cord Stimulator (SCS) in place.

The investigators hypothesize that chronic pain patients will have higher heat pain threshold and heat pain tolerance over the painful areas with the SCS on.

QST (Quantitative Sensory Testing, a heat/cold simulation test) might be an objective helpful tool for prudent patient selection for an expensive and invasive procedure for future SCS placement.

Description:

Sixty subjects who already have an implanted SCS device for pain management at the MGH Center for Pain Medicine and other Partners affiliated pain centers will be enrolled.

Inclusion Criteria:

1. Subject is 18 years or older.

2. Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.

Exclusion Criteria:

1. Subject has neurological disease or a condition causing sensory deficit to the painful area.

2. Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.

3. Subjects who are unable to travel to the study center.

It will be a one time outpatient visit study, which will include the following:

1. Brief pain history and Neurological examination

• Medical History (including medication use);

• Pain location, intensity, character and if known, etiology, duration;

• Maps of pain locations and paresthesia locations;

• Sensory neurological examination (e.g., alcohol swab, cotton swab, pinprick and vibration);

• A check on routine vital signs (blood pressure, pulse, pulse oximetry).

2. QST will include the following:

• Warm sensation, heat pain threshold, heat pain tolerance and wind-up. A cut-off of 53°C for heat will be preset to avoid tissue damage.

• QST will be done on two areas; painful area and non-painful area without paresthesia with the SCS turned off.

• Subject will then turn on SCS and a repeat QST will be performed on the painful and non-painful areas.

• QST tests will be performed in a quiet room at temperature 25º 2° C. The time and duration of the QST tests will be recorded.

QST will be performed at least 4 hours and no later than 6 hours after the last dose of long acting opioid and after last SCS on time. In this way the investigators will try to avoid recording possible end dose withdrawal and provide sufficient time for the subject to return to baseline for their SCS therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19
• Est. completion date: December 20, 2016
• Est. primary completion date: August 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subject is 18 years or older.

• Subject has an SCS device implanted for at least one month for pain control. This requirement is set to ensure that the subject becomes familiarized with the therapy and has recovered from the surgical implantation of the SCS device.

Exclusion Criteria:

• Subject has neurological disease or a condition causing sensory deficit to the painful area.

• Subject had recent therapy that may influence QST results, e.g., neuroablative procedure within two-months.

• Subjects who are unable to travel to the study center.

Related Conditions & MeSH terms

• Chronic Pain

Locations

Country	Name	City	State
United States	MGH Center for Translational Pain Research	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Warm Sensation (WS) Threshold- Pain Site	WS threshold is a type of Quantitative Sensory Test (QST). A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop stimulation when they first perceived a warm sensation. Subjects performed this test with their SCS off and again with their SCS on.	WS threshold is assessed once at Visit 1
Primary	Heat Pain (HP) Threshold- Pain Site	Heat Pain threshold is a type of QST. A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop the stimulation when pain was first detected. Subjects performed this test with their SCS off and again with their SCS on.	HP threshold is assessed once at Visit 1
Primary	Heat Pain Tolerance- Pain Site	Heat Pain threshold is a type of QST. A contact thermode was attached to the subject's painful area that has SCS coverage. The thermode increased by 1°C/sec from a baseline of 32°C. Subjects were instructed to stop the stimulation when pain was no longer tolerable. Subjects performed this test with their SCS off and again with their SCS on.	Heat Pain Tolerance is assessed once at Visit 1